Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for prevention of gentamicin-induced nephrotoxicity
IRCT20161010030246N5Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in drug-induced nephropathy (DIN), sponsored by Shiraz University of Medical Sciences. Started Jul 2019; status: completed.
02
Drugs
pentoxifylline
03
Conditions
drug-induced nephropathy (DIN)
Beyond the preview
Go deeper on IRCT20161010030246N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161010030246N5.